{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:03:49Z","timestamp":1784653429680,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s15010-020-01393-9","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:02:42Z","timestamp":1581526962000},"page":"275-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Epidemiology of candidemia and impact of infectious disease consultation on survival and care"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6197-0444","authenticated-orcid":false,"given":"Arno","family":"Mohr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Joha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hanses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Salzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hitzenbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B de Pauw","year":"2008","unstructured":"de Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1001\/archinte.1988.00380120094019","volume":"148","author":"SB Wey","year":"1988","unstructured":"Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642\u20135.","journal-title":"Arch Intern Med"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172\u20137.","journal-title":"Clin Infect Dis"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1128\/JCM.00179-11","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Sulim S, Holm A, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011;49:3300\u20138.","journal-title":"J Clin Microbiol"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/cid\/civ293","volume":"61","author":"OA Cornely","year":"2015","unstructured":"Cornely OA, Gachot B, Akan H, et al. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis. 2015;61:324\u201331.","journal-title":"Clin Infect Dis"},{"key":"1393_CR6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1128\/JCM.44.5.1782-1787.2006","volume":"44","author":"SA Messer","year":"2006","unstructured":"Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp and Aspergillus spp: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol. 2006;44:1782\u20137.","journal-title":"J Clin Microbiol"},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s15010-018-1217-2","volume":"47","author":"M Papadimitriou-Olivgeris","year":"2019","unstructured":"Papadimitriou-Olivgeris M, Spiliopoulou A, Kolonitsiou F, et al. Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009\u20132017) in a university Greek hospital. Infection. 2019;47:209\u201316.","journal-title":"Infection"},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445\u2013566.","journal-title":"N Engl J Med"},{"key":"1393_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1097\/CCM.0b013e31816fc4cd","volume":"36","author":"JK Chow","year":"2008","unstructured":"Chow JK, Golan Y, Ruthazer R, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med. 2008;36:1993\u20138.","journal-title":"Crit Care Med"},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/321811","volume":"33","author":"HM Blumberg","year":"2001","unstructured":"Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33:177\u201386.","journal-title":"Clin Infect Dis"},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","volume":"20","author":"RP Wenzel","year":"1995","unstructured":"Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis. 1995;20:1531\u20134.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"1393_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl 7):19\u201337.","journal-title":"Clin Microbiol Infect"},{"key":"1393_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/myc.12746","volume":"61","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Hoenigl M, Koehler P, et al. EQUAL Candida Score: an ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management. Mycoses. 2018;61:326\u201330.","journal-title":"Mycoses"},{"key":"1393_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","volume":"27","author":"MC Arendrup","year":"2014","unstructured":"Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis. 2014;27:484\u201392.","journal-title":"Curr Opin Infect Dis"},{"key":"1393_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11046-014-9786-9","volume":"178","author":"L Milazzo","year":"2014","unstructured":"Milazzo L, Peri AM, Mazzali C, et al. Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014. Mycopathologia. 2014;178:227\u201341.","journal-title":"Mycopathologia"},{"key":"1393_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, et al. Population-based analysis of invasive fungal infections, France, 2001\u20132010. Emerg Infect Dis. 2014;20:1149\u201355.","journal-title":"Emerg Infect Dis"},{"key":"1393_CR18","doi-asserted-by":"publisher","first-page":"e0215996","DOI":"10.1371\/journal.pone.0215996","volume":"14","author":"M Ishikane","year":"2019","unstructured":"Ishikane M, Hayakawa K, Kutsuna S, Takeshita N, Ohmagari N. The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years. PLoS ONE. 2019;14:e0215996.","journal-title":"PLoS ONE"},{"key":"1393_CR19","unstructured":"Statistische Bundesamt ZB. Diagnosedaten der Krankenh\u00e4user ab 2000. Available at: https:\/\/www.gbe-bund.de\/oowa921-install\/servlet\/oowa\/aw92\/dboowasys921.xwdevkit\/xwd_init?gbe.isgbetol\/xs_start_neu\/&p_aid=3&p_aid=61403017&nummer=550&p_sprache=D&p_indsp=-&p_aid=15744824. Accessed 2 July 2019."},{"key":"1393_CR20","unstructured":"Statistisches Bundesamt. Statistisches Jahrbuch 2018. Available at: https:\/\/www.destatis.de\/DE\/Themen\/Querschnitt\/Jahrbuch\/statistisches-jahrbuch-2018-dl.pdf?__blob=publicationFile&v=5. Accessed 2 July 2019."},{"key":"1393_CR21","unstructured":"Statistische Bundesamt ZB. Case Mix Case Mix Index und Erl\u00f6svolumen der vollstation\u00e4ren Patientinnen und Patienten in Krankenh\u00e4usern. Available at: https:\/\/www.gbe-bund.de\/oowa921-install\/servlet\/oowa\/aw92\/dboowasys921.xwdevkit\/xwd_init?gbe.isgbetol\/xs_start_neu\/&p_aid=i&p_aid=31681490&nummer=113&p_sprache=D&p_indsp=-&p_aid=43231210. Accessed 2 July 2019."},{"key":"1393_CR22","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","volume":"17","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, de Almeida JN, Slavin MA, Chen SC-A, Sorrell TC. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17:e344\u2013e356356.","journal-title":"Lancet Infect Dis"},{"key":"1393_CR23","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1128\/JCM.02363-09","volume":"48","author":"GM Lyon","year":"2010","unstructured":"Lyon GM, Karatela S, Sunay S, Adiri Y. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48:1270\u20135.","journal-title":"J Clin Microbiol"},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1086\/529435","volume":"46","author":"JK Chow","year":"2008","unstructured":"Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008;46:1206\u201313.","journal-title":"Clin Infect Dis"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"e24198","DOI":"10.1371\/journal.pone.0024198","volume":"6","author":"M Bassetti","year":"2011","unstructured":"Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE. 2011;6:e24198.","journal-title":"PLoS ONE"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s15010-015-0791-9","volume":"43","author":"J Fischer","year":"2015","unstructured":"Fischer J, Jung N, Robinson N, Lehmann C. Sex differences in immune responses to infectious diseases. Infection. 2015;43:399\u2013403.","journal-title":"Infection"},{"key":"1393_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MD.0b013e3181b8fccb","volume":"88","author":"T Lahey","year":"2009","unstructured":"Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore). 2009;88:263\u20137.","journal-title":"Medicine (Baltimore)"},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/cid\/civ120","volume":"60","author":"AD Bai","year":"2015","unstructured":"Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60:1451\u201361.","journal-title":"Clin Infect Dis"},{"key":"1393_CR29","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.2146\/ajhp170113","volume":"74","author":"TM Jones","year":"2017","unstructured":"Jones TM, Drew RH, Wilson DT, Sarubbi C, Anderson DJ. Impact of automatic infectious diseases consultation on the management of fungemia at a large academic medical center. Am J Health Syst Pharm. 2017;74:1997\u20132003.","journal-title":"Am J Health Syst Pharm"},{"key":"1393_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jinf.2018.03.011","volume":"77","author":"R Murri","year":"2018","unstructured":"Murri R, Giovannenze F, Camici M, et al. Systematic clinical management of patients with candidemia improves survival. J Infect. 2018;77:145\u201350.","journal-title":"J Infect"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1086\/380796","volume":"38","author":"PG Pappas","year":"2004","unstructured":"Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161\u201389.","journal-title":"Clin Infect Dis"},{"key":"1393_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/1120009X.2018.1507086","volume":"30","author":"F Menichetti","year":"2018","unstructured":"Menichetti F, Bertolino G, Sozio E, et al. Impact of infectious diseases consultation as a part of an antifungal stewardship programme on candidemia outcome in an Italian tertiary-care. Univ Hosp J Chemother. 2018;30:304\u20139.","journal-title":"Univ Hosp J Chemother"},{"key":"1393_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s15010-018-1191-8","volume":"47","author":"S Rieg","year":"2019","unstructured":"Rieg S, Hitzenbichler F, Hagel S, et al. Infectious disease services: a survey from four university hospitals in Germany. Infection. 2019;47:27\u201333.","journal-title":"Infection"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-020-01393-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T13:55:53Z","timestamp":1613051753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-020-01393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s15010-020-01393-9","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"4 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AM and FHi: travel grants from Gilead Sciences. BS: educational grants from Gilead Sciences. MS: lecture fee from Beckton Dickinson. FH: speaker and travel grants from Correvio, other grants (clinical study reimbursement) from Basilea and Portola.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}